Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.

Journal of neuropathology and experimental neurology - 1 Aug 2017

Pratt Drew, Pittaluga Stefania, Palisoc Maryknoll, Fetsch Patricia, Xi Liqiang, Raffeld Mark, Gilbert Mark R, Quezado Martha

Abstract excerpt

Glioblastoma is an aggressive, often recalcitrant disease. In the majority of cases, prognosis is dismal and current therapies only moderately prolong survival. Immunotherapy is increasingly being recognized as an effective treatment modality. CD70 is a transmembrane protein that shows restricted expression in tissue but has been described in various malignancies. Therapeutic targeting of CD70 has demonstrated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Databases, Factual

Share to Glial Fibrillary Acidic Protein

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Tissue Array Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 28789475
DOI: 10.1093/jnen/nlx051
PMCID: PMC6251514

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.PMID 28789475Read ↗

Immune checkpoint expression and therapeutic implications in IDH1-mutant and wild-type glioblastomas.Semantic proximity Read ↗

Molecular and clinical characterization of CD163 expression via large-scale analysis in gliomaSemantic proximity Read ↗

Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various CancersSemantic proximity Read ↗

Crosstalk between CD180-overexpression macrophages and glioma cells worsens patient survival through malignant phenotype promotion and immunosuppressive regulation.Semantic proximity Read ↗

A mechanistic, functional, and clinical perspective on targeting CD70 in cancerSemantic proximity Read ↗

Analysis of immunobiologic markers in primary and recurrent glioblastoma.Semantic proximity Read ↗

Immunogenetics of glioblastoma: the future of personalized patient managementSemantic proximity Read ↗

Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer typesSemantic proximity Read ↗

Immunophenotypic Profile of Adult Glioblastoma IDH-Wildtype Microenvironment: A Cohort StudySemantic proximity Read ↗

Molecular and clinical characterization of TMEM71 expression at the transcriptional level in gliomaSemantic proximity Read ↗

Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1.Semantic proximity Read ↗

Integrated analysis reveals CP is a potential biomarker and therapeutic target in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.